---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-018381"
form_type: "8-K"
ticker: "GCTK"
cik: "0001506983"
company_name: "Glucotrack, Inc."
filed_at: "2023-05-19T23:59:59+00:00"
generated_at: "2026-06-14T19:43:23.592039+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# GlucoTrack regains Nasdaq compliance after $10M public offering

## Summary
- Cured Nasdaq Rule 5550(b)(1) stockholders' equity deficiency below $2.5M minimum.
- Raised ~$10M gross proceeds from April 17, 2023 firmly committed public offering.
- Nasdaq will continue to monitor compliance; delisting risk remains if not maintained.
- November 2022 notice triggered by Q3 2022 Form 10-Q equity shortfall.

## SEC filing metadata
- accession: 0001493152-23-018381
- form_type: 8-K
- ticker: GCTK
- cik: 0001506983
- company_name: Glucotrack, Inc.
- filed_at: 2023-05-19T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1506983/000149315223018381/0001493152-23-018381-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1506983/000149315223018381/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-018381
- JSON: https://secwatch.observer/filing/0001493152-23-018381.json
- Plain text: https://secwatch.observer/filing/0001493152-23-018381.txt

## Key facts
- Listing & Compliance Notices
  Glucotrack, Inc. received a nasdaq compliance regained notice regarding stockholders equity (rules 5550(b)(1)).
  - Exchange: nasdaq
  - Notice: compliance regained
  - Deficiency: stockholders equity
  - Rules: 5550(b)(1)
  source text: common stock with gross proceeds to the Company of approximately $10.0 million, before deducting underwriting discounts and other estimated expenses paid by the Company. The deficiency cured was the November 22, 2022 notice from Nasdaq that the Company was not in compliance with Nasdaq Listing Rule 5550(b)(1) since its third quarter 2022 Form 10-Q reported stockholders’ equity under the $2.5 million required minimum. The Company acknowledges that Nasdaq will continue to monitor the Company’s ongoing compliance with the stockholders’ equity requirement and, if at the time of its next periodic r
  evidence_url: https://www.sec.gov/Archives/edgar/data/1506983/000149315223018381/0001493152-23-018381-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.